Search Results - "Chee CE"

Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423.

Authors: Chee CE Jett JR Bernath AM Jr et al.

Source: Cancer (0008543X). 5/15/2010, Vol. 116 Issue 10, p2382-2389. 8p.

71-year-old woman with fever and altered mental status.

Authors: Chee CE Mohr DN

Source: Mayo Clinic Proceedings. Feb2007, Vol. 82 Issue 2, p237-240. 4p.

URL: 24013423

Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

Authors: Pelletier M Yang J Joshi M et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

Authors: R Choo J Jeraj SN Sundar R et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Jun 09; Vol. 17, pp. 17588359251339930. Date of Electronic Publication: 2025 Jun 09 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort study.

Authors: Mane E Tacey M Loveday B et al.

Source: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2026 Apr 07; Vol. 88 (6), pp. 3142-3148. Date of Electronic Publication: 2026 Apr 07 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Country of Publication: England NLM ID: 101616869 Publication Model: eCollection Cited Medium: Print ISSN: 2049-0801 (Print) Linking ISSN: 20490801 NLM ISO Abbreviation: Ann Med Surg (Lond) Subsets: PubMed not MEDLINE

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial.

Authors: Blasiak A Truong ATL Foo N et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2025 Feb 21; Vol. 9 (1), pp. 49. Date of Electronic Publication: 2025 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Trends in lung cancer incidence and stage at diagnosis in Singapore: a population-based joinpoint regression analysis by age, sex, and smoking status.

Authors: Juang YR Hu M Hui M et al.

Source: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2025 Dec 19; Vol. 66, pp. 101779. Date of Electronic Publication: 2025 Dec 19 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101774968 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-6065 (Electronic) Linking ISSN: 26666065 NLM ISO Abbreviation: Lancet Reg Health West Pac Subsets: PubMed not MEDLINE

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore.

Authors: Chee CE Khara JS Cheong J et al.

Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Jun; Vol. 24 (5), pp. 631-641. Date of Electronic Publication: 2024 May 22.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE

Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit.

Authors: Walsh RJ Ong R Cheo SW et al.

Source: Frontiers in oncology [Front Oncol] 2024 May 15; Vol. 14, pp. 1342346. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry.

Authors: Hayat F Chiu S Stuart A et al.

Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2025 Oct 31; Vol. 16 (5), pp. 2377-2387. Date of Electronic Publication: 2025 Oct 24.

Publication Type: Journal Article

Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer.

Authors: Tai D Conroy T Lee JJX et al.

Source: ESMO open [ESMO Open] 2025 Oct; Vol. 10 (10), pp. 105826. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Consensus Statement; Journal Article; Practice Guideline

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Functional Precision in Pancreatic Cancer: Redefining Biomarkers with Patient-Derived Organoids.

Authors: Chew CA Wun CM Lee YF et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Sep 18; Vol. 26 (18). Date of Electronic Publication: 2025 Sep 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024.

Authors: Le Minh G Lucky SS Pervaiz S et al.

Source: Cancer research [Cancer Res] 2025 Aug 01; Vol. 85 (15), pp. 2784-2787.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Authors: Chee CE Ooi M Lee SC et al.

Source: Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 391-402. Date of Electronic Publication: 2023 Apr 15.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer.

Authors: Choo J Kua LF Soe MY et al.

Source: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2023 May; Vol. 26 (3), pp. 393-404. Date of Electronic Publication: 2023 Feb 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.

Authors: Plummer R Sodergren MH Hodgson R et al.

Source: Cell reports. Medicine [Cell Rep Med] 2025 Apr 15; Vol. 6 (4), pp. 102041. Date of Electronic Publication: 2025 Mar 31.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.

Authors: Catenacci DV Kang YK Uronis HE et al.

Source: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2023 Apr 25; Vol. 37 (4), pp. 176-183.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Authors: Walpole I Lee B Shapiro J et al.

Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Feb; Vol. 19 (1), pp. 214-225. Date of Electronic Publication: 2022 Jul 13.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647].

Authors: Chen LT Vogel A Hsu C et al.

Source: ESMO open [ESMO Open] 2025 Jan; Vol. 10 (1), pp. 104074. Date of Electronic Publication: 2024 Dec 19.

Publication Type: Published Erratum

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE; PubMed not MEDLINE

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.

Authors: Chia DKA Sundar R Kim G et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8597-8605. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE